Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA shakes up pharma leadership

Stefan Oschmann becomes deputy CEO as Belén Garijo assumes more responsibility

merck stefan oschmannMerck KGaA has made several changes to the leadership of its pharmaceutical business.

At the start of next year Stefan Oschmann (top right), current CEO for pharma, will move to a new role as deputy CEO of the entire group. He will also become vice chairman of the executive board.

Oschmann will be replaced by Belén Garijo (bottom right), current CEO of Merck's biotech division Merck Serono in a move that will expand her responsibilities, adding oversight for consumer health, allergy and biosimilars.

Johannes Baillou, chairman of the board of partners of Merck, said: “With today's management decisions we strengthen Merck's leadership team and prepare the ground for continuity to reach our ambitious growth targets until the year 2018 and beyond.”

Belén Garijo, Merck KGaAThe announced comes one year after Garijo left her role as Merck Serono's chief operating officer to replace Oschmann as CEO of the division.

Garijo's career prior to joining Merck in 2011 included a spell at Sanofi, where she led global integrations of the company's acquisition of Genzyme.

Oschmann also joined Merck in 2011, having spent the previous 11 years at its US-based namesake Merck & Co, known as MSD outside the US and Canada.

19th September 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...